Semaglutide

Price range: £43.00 through £140.00

+ Free Shipping

YOUR ORDER COMES WITH;

  • 10 VIALS x 5mg of Semaglutide Base Research Peptide

  • FREE: Bacteriostatic Water (30ml), Sterile Syringes (1ml & 3ml, various gauges), and Alcohol Swabs

  • DOSING SCHEDULE: Comprehensive laboratory administration protocol for research models

  • USAGE INSTRUCTIONS: Detailed reconstitution guide, stability parameters, and handling procedures for this acylated peptide

  • A COPY OF LAB RESULTS: Certificate of Analysis (CoA) confirming purity, identity, modification, and sterility

Semaglutide is a long-acting, acylated GLP-1 receptor agonist analog supplied for advanced research into sustained incretin activity, weight management mechanisms, and metabolic disease pathways. This complete research kit includes all necessary components for standardized experimental studies in pharmacology and metabolic science.

SKU: N/A Category:
Guaranteed Safe Checkout

Long-Acting GLP-1 Analog for Metabolic Pharmacology Research

Semaglutide is a 31-amino acid peptide analog of human glucagon-like peptide-1 (GLP-1) engineered with three key modifications: an aminoisobutyric acid (Aib) substitution at position 8 to resist DPP-4 degradation, a C-18 fatty diacid side chain attached via a γGlu-2xOEG linker at Lys²⁶ for albumin binding and prolonged half-life, and an arginine-to-lysine substitution at position 34 (sequence: HXEGTFTSDVSSYLEGQAAKEFIAWLVKGRG; where X=Aib). These modifications create a research tool with significantly extended in-vivo activity compared to native GLP-1, allowing scientists to study the effects of sustained GLP-1 receptor activation on glucose-dependent insulin secretion, glucagon suppression, gastric emptying, satiety signaling, and potential neuroprotective/cardioprotective pathways. Supplied as the research-grade base peptide (not a specific salt form), this lyophilized compound is intended strictly for controlled, non-human laboratory investigation into the mechanisms of next-generation incretin therapies.

Complete Research Kit Contents & Verification

Each research order provides a complete experimental package designed for sophisticated pharmacological research:

  • Primary Research Compound: 10 sterile glass vials containing 5mg of lyophilized Semaglutide base peptide powder per vial.

  • Reconstitution Solution: 30ml vial of sterile Bacteriostatic Water (0.9% Benzyl Alcohol). Note: For certain in-vitro assays, researchers may prefer specific buffers to maintain albumin-free conditions for binding studies.

  • Laboratory Administration Tools: Pack of sterile syringes (1ml insulin syringes for precision, 3ml for reconstitution) with various gauges and alcohol swabs.

  • Research Protocol Documentation:

    • Dosing Schedule: Administration protocol for research models, accounting for the peptide’s extended half-life (suitable for intermittent dosing in chronic studies).

    • Usage Instructions: Critical guide covering the specific handling of this acylated peptide: gentle reconstitution to avoid foaming/aggregation, stability considerations (albumin binding in biological matrices), storage at -20°C to -80°C, and avoidance of adsorption to surfaces.

  • Quality Verification: Certificate of Analysis (CoA) provided with each batch, detailing:

    • Purity Analysis (>97% by HPLC/UPLC – critical due to complexity)

    • Structural Verification (Mass Spectrometry):

      • Confirmation of Aib at position 8

      • Confirmation of C-18 fatty diacid acylation at Lys²⁶ via linker

      • Full sequence confirmation

    • Molecular Weight Confirmation (~4114 Da)

    • Related Substances & Degradation Products (e.g., deamidation, dimerization)

    • Sterility Testing Results

    • Endotoxin Levels (<10 EU/mg)

    • Residual Solvents (from synthesis & acylation)

    • Free Fatty Acid Content & Acylation Efficiency

Research Applications & Scientific Utility

In a laboratory setting, research-grade Semaglutide enables high-level investigation into sustained GLP-1 pharmacology. Primary research applications include:

  • Chronic Disease Models: Studying long-term metabolic effects in diet-induced obesity, type 2 diabetes, and NAFLD/NASH models with weekly or less frequent dosing schedules.

  • Mechanism of Prolonged Action: Investigating the kinetics of albumin binding, tissue distribution, and receptor activation over extended periods.

  • Comparative Pharmacology: Serving as a gold-standard comparator for evaluating novel GLP-1 analogs, dual/triple agonists, or other long-acting formulations in development.

  • Non-Metabolic Effects: Researching potential benefits in neurodegenerative (Alzheimer’s, Parkinson’s) or cardiovascular disease models, independent of weight loss.

  • Combination Therapy Research: Exploring synergistic effects with other hormone analogs (e.g., amylin, GIP agonists) in metabolic studies.

Laboratory Handling & Safety Protocol – SPECIAL CONSIDERATIONS

  • Storage: Store unopened vials at -20°C or preferably -80°C. The fatty acid chain can oxidize. Aliquot reconstituted solution immediately and store at -80°C. Avoid repeated freeze-thaw cycles.

  • Reconstitution: Crucial Step. Use the provided bacteriostatic water. Add slowly down the vial wall. Let sit for 30-60 minutes at 4°C, then swirl very gently. Do NOT shake or vortex. The solution may appear slightly opalescent due to the fatty acid chain; this is normal if mild.

  • Binding & Adsorption: This peptide readily binds to albumin and may adsorb to plastic. Use low-binding tubes and account for this in dose calculations for in-vivo work. For cell studies, pre-incubate with media containing serum.

  • Laboratory Safety: Standard PPE required. Handle as a potent, long-acting biological research compound.

⚠️ Critical Compliance & Intended Use Disclaimer:

THIS PRODUCT IS SOLD FOR RESEARCH USE ONLY (RUO). NOT FOR HUMAN OR VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.

  1. Intended Use: Semaglutide is supplied as a biochemical reagent for laboratory research purposes only. It is intended for use by qualified researchers in controlled non-human settings. The “dosing schedule” is for research models only.

  2. Not for Human Consumption: This product is NOT Ozempic®, Wegovy®, or Rybelsus®. It is not a drug, weight loss treatment, or diabetes medication. It is a raw peptide for research. The provided supplies are for laboratory use.

  3. Regulatory Status: This product has not been manufactured in an FDA-approved facility, nor has it been evaluated or approved for any use by the FDA or any global health authority.

  4. Intellectual Property Notice: Semaglutide is a patented compound of Novo Nordisk A/S. This supply is for non-commercial research use only under applicable exemptions.

  5. Researcher Responsibility: The purchaser assumes full responsibility for compliance with all laws and for ensuring this compound is used exclusively for legitimate, non-human research.

QUANTITY

10MG, 20MG, 30MG, 50MG

Reviews

There are no reviews yet.

Be the first to review “Semaglutide”

Your email address will not be published. Required fields are marked *

Shopping Cart
Scroll to Top